nodes	percent_of_prediction	percent_of_DWPC	metapath
Dactinomycin—ocular cancer—sarcoma	0.121	0.202	CtDrD
Dactinomycin—uterine cancer—sarcoma	0.0756	0.126	CtDrD
Dactinomycin—ABCC6—Etoposide—sarcoma	0.071	0.221	CbGbCtD
Dactinomycin—melanoma—sarcoma	0.0691	0.115	CtDrD
Dactinomycin—skin cancer—sarcoma	0.0643	0.107	CtDrD
Dactinomycin—muscle cancer—sarcoma	0.06	0.1	CtDrD
Dactinomycin—testicular cancer—sarcoma	0.0562	0.0938	CtDrD
Dactinomycin—germ cell cancer—sarcoma	0.0539	0.0898	CtDrD
Dactinomycin—kidney cancer—sarcoma	0.0502	0.0837	CtDrD
Dactinomycin—peripheral nervous system neoplasm—sarcoma	0.0497	0.0829	CtDrD
Dactinomycin—ABCC6—Doxorubicin—sarcoma	0.0485	0.151	CbGbCtD
Dactinomycin—ABCC1—Mitoxantrone—sarcoma	0.0332	0.104	CbGbCtD
Dactinomycin—ABCC1—Epirubicin—sarcoma	0.0269	0.0838	CbGbCtD
Dactinomycin—ABCC1—Vincristine—sarcoma	0.0229	0.0713	CbGbCtD
Dactinomycin—ABCG2—Mitoxantrone—sarcoma	0.0222	0.0693	CbGbCtD
Dactinomycin—ABCC1—Etoposide—sarcoma	0.021	0.0653	CbGbCtD
Dactinomycin—ABCG2—Vincristine—sarcoma	0.0153	0.0477	CbGbCtD
Dactinomycin—ABCC1—Doxorubicin—sarcoma	0.0143	0.0445	CbGbCtD
Dactinomycin—ABCG2—Etoposide—sarcoma	0.014	0.0437	CbGbCtD
Dactinomycin—ABCG2—Doxorubicin—sarcoma	0.00957	0.0298	CbGbCtD
Dactinomycin—ABCB1—Mitoxantrone—sarcoma	0.00802	0.025	CbGbCtD
Dactinomycin—ABCB1—Vincristine—sarcoma	0.00552	0.0172	CbGbCtD
Dactinomycin—ABCB1—Etoposide—sarcoma	0.00506	0.0158	CbGbCtD
Dactinomycin—ABCC6—dermis—sarcoma	0.00463	0.388	CbGeAlD
Dactinomycin—ABCB1—Doxorubicin—sarcoma	0.00345	0.0107	CbGbCtD
Dactinomycin—ABCC6—Podofilox—Etoposide—sarcoma	0.00165	1	CbGdCrCtD
Dactinomycin—ABCC6—hematopoietic system—sarcoma	0.000695	0.0582	CbGeAlD
Dactinomycin—ABCC6—connective tissue—sarcoma	0.000669	0.056	CbGeAlD
Dactinomycin—SLC22A5—mammary gland—sarcoma	0.000403	0.0338	CbGeAlD
Dactinomycin—ABCC6—liver—sarcoma	0.00036	0.0302	CbGeAlD
Dactinomycin—Sepsis—Thiotepa—sarcoma	0.00034	0.00517	CcSEcCtD
Dactinomycin—Myelosuppression—Epirubicin—sarcoma	0.000337	0.00511	CcSEcCtD
Dactinomycin—ABCC1—myometrium—sarcoma	0.000325	0.0272	CbGeAlD
Dactinomycin—Extravasation—Etoposide—sarcoma	0.000323	0.0049	CcSEcCtD
Dactinomycin—Ascites—Doxorubicin—sarcoma	0.000322	0.00488	CcSEcCtD
Dactinomycin—Hepatic failure—Thiotepa—sarcoma	0.000317	0.00481	CcSEcCtD
Dactinomycin—Ulcerative stomatitis—Doxorubicin—sarcoma	0.000317	0.00481	CcSEcCtD
Dactinomycin—Mouth ulceration—Vincristine—sarcoma	0.000315	0.00478	CcSEcCtD
Dactinomycin—Myelosuppression—Doxorubicin—sarcoma	0.000312	0.00473	CcSEcCtD
Dactinomycin—Ulcer—Etoposide—sarcoma	0.000298	0.00452	CcSEcCtD
Dactinomycin—Sepsis—Mitoxantrone—sarcoma	0.000294	0.00446	CcSEcCtD
Dactinomycin—ABCC1—seminal vesicle—sarcoma	0.000294	0.0246	CbGeAlD
Dactinomycin—SLC22A5—myometrium—sarcoma	0.000286	0.0239	CbGeAlD
Dactinomycin—Phlebitis—Mitoxantrone—sarcoma	0.000285	0.00433	CcSEcCtD
Dactinomycin—Hepatic failure—Vincristine—sarcoma	0.000281	0.00427	CcSEcCtD
Dactinomycin—ABCG2—myometrium—sarcoma	0.000269	0.0225	CbGeAlD
Dactinomycin—Febrile neutropenia—Epirubicin—sarcoma	0.000263	0.00399	CcSEcCtD
Dactinomycin—SLC22A5—seminal vesicle—sarcoma	0.000258	0.0216	CbGeAlD
Dactinomycin—Oesophagitis—Etoposide—sarcoma	0.000258	0.00391	CcSEcCtD
Dactinomycin—Eruption—Epirubicin—sarcoma	0.000257	0.0039	CcSEcCtD
Dactinomycin—Aspartate aminotransferase increased—Thiotepa—sarcoma	0.000256	0.00389	CcSEcCtD
Dactinomycin—Mouth ulceration—Etoposide—sarcoma	0.000255	0.00387	CcSEcCtD
Dactinomycin—Folliculitis—Epirubicin—sarcoma	0.000251	0.00382	CcSEcCtD
Dactinomycin—Sepsis—Etoposide—sarcoma	0.000245	0.00371	CcSEcCtD
Dactinomycin—ABCG2—seminal vesicle—sarcoma	0.000243	0.0204	CbGeAlD
Dactinomycin—Febrile neutropenia—Doxorubicin—sarcoma	0.000243	0.00369	CcSEcCtD
Dactinomycin—Eruption—Doxorubicin—sarcoma	0.000238	0.00361	CcSEcCtD
Dactinomycin—Phlebitis—Etoposide—sarcoma	0.000237	0.00361	CcSEcCtD
Dactinomycin—Pancytopenia—Thiotepa—sarcoma	0.000234	0.00355	CcSEcCtD
Dactinomycin—Folliculitis—Doxorubicin—sarcoma	0.000233	0.00353	CcSEcCtD
Dactinomycin—Aspartate aminotransferase increased—Vincristine—sarcoma	0.000227	0.00345	CcSEcCtD
Dactinomycin—Hepatomegaly—Epirubicin—sarcoma	0.000223	0.00339	CcSEcCtD
Dactinomycin—Aspartate aminotransferase increased—Mitoxantrone—sarcoma	0.000221	0.00336	CcSEcCtD
Dactinomycin—Pneumonia—Thiotepa—sarcoma	0.000221	0.00335	CcSEcCtD
Dactinomycin—Stomatitis—Thiotepa—sarcoma	0.000214	0.00325	CcSEcCtD
Dactinomycin—SLC22A5—skin of body—sarcoma	0.000213	0.0179	CbGeAlD
Dactinomycin—ABCC1—cardiac atrium—sarcoma	0.000212	0.0178	CbGeAlD
Dactinomycin—ABCC1—uterus—sarcoma	0.000211	0.0177	CbGeAlD
Dactinomycin—Pancytopenia—Vincristine—sarcoma	0.000207	0.00315	CcSEcCtD
Dactinomycin—Hepatomegaly—Doxorubicin—sarcoma	0.000207	0.00314	CcSEcCtD
Dactinomycin—Agranulocytosis—Thiotepa—sarcoma	0.000205	0.00311	CcSEcCtD
Dactinomycin—Neutropenia—Vincristine—sarcoma	0.000204	0.0031	CcSEcCtD
Dactinomycin—Pancytopenia—Mitoxantrone—sarcoma	0.000202	0.00306	CcSEcCtD
Dactinomycin—Necrosis—Epirubicin—sarcoma	0.000201	0.00306	CcSEcCtD
Dactinomycin—Neutropenia—Mitoxantrone—sarcoma	0.000199	0.00302	CcSEcCtD
Dactinomycin—Pneumonia—Vincristine—sarcoma	0.000196	0.00297	CcSEcCtD
Dactinomycin—Pneumonia—Mitoxantrone—sarcoma	0.000191	0.00289	CcSEcCtD
Dactinomycin—Stomatitis—Vincristine—sarcoma	0.00019	0.00288	CcSEcCtD
Dactinomycin—SLC22A5—cardiac atrium—sarcoma	0.000186	0.0156	CbGeAlD
Dactinomycin—Necrosis—Doxorubicin—sarcoma	0.000186	0.00283	CcSEcCtD
Dactinomycin—Stomatitis—Mitoxantrone—sarcoma	0.000185	0.0028	CcSEcCtD
Dactinomycin—ABCC1—tendon—sarcoma	0.000185	0.0155	CbGeAlD
Dactinomycin—Toxic epidermal necrolysis—Etoposide—sarcoma	0.000184	0.0028	CcSEcCtD
Dactinomycin—Extravasation—Epirubicin—sarcoma	0.000181	0.00275	CcSEcCtD
Dactinomycin—Agranulocytosis—Mitoxantrone—sarcoma	0.000177	0.00269	CcSEcCtD
Dactinomycin—Dysphagia—Etoposide—sarcoma	0.000177	0.00268	CcSEcCtD
Dactinomycin—Chills—Thiotepa—sarcoma	0.000177	0.00268	CcSEcCtD
Dactinomycin—ABCG2—uterus—sarcoma	0.000175	0.0146	CbGeAlD
Dactinomycin—Alopecia—Thiotepa—sarcoma	0.000174	0.00264	CcSEcCtD
Dactinomycin—Hypocalcaemia—Epirubicin—sarcoma	0.000173	0.00262	CcSEcCtD
Dactinomycin—Erythema—Thiotepa—sarcoma	0.000172	0.0026	CcSEcCtD
Dactinomycin—Hepatitis—Mitoxantrone—sarcoma	0.00017	0.00258	CcSEcCtD
Dactinomycin—Pharyngitis—Mitoxantrone—sarcoma	0.000169	0.00256	CcSEcCtD
Dactinomycin—Pancytopenia—Etoposide—sarcoma	0.000168	0.00255	CcSEcCtD
Dactinomycin—Extravasation—Doxorubicin—sarcoma	0.000168	0.00254	CcSEcCtD
Dactinomycin—Ulcer—Epirubicin—sarcoma	0.000167	0.00254	CcSEcCtD
Dactinomycin—Neutropenia—Etoposide—sarcoma	0.000165	0.00251	CcSEcCtD
Dactinomycin—SLC22A5—tendon—sarcoma	0.000162	0.0136	CbGeAlD
Dactinomycin—Hypocalcaemia—Doxorubicin—sarcoma	0.00016	0.00242	CcSEcCtD
Dactinomycin—Pneumonia—Etoposide—sarcoma	0.000159	0.00241	CcSEcCtD
Dactinomycin—Anaemia—Thiotepa—sarcoma	0.000159	0.00241	CcSEcCtD
Dactinomycin—Stevens-Johnson syndrome—Etoposide—sarcoma	0.000156	0.00237	CcSEcCtD
Dactinomycin—Ulcer—Doxorubicin—sarcoma	0.000155	0.00235	CcSEcCtD
Dactinomycin—Alopecia—Vincristine—sarcoma	0.000154	0.00234	CcSEcCtD
Dactinomycin—Stomatitis—Etoposide—sarcoma	0.000154	0.00233	CcSEcCtD
Dactinomycin—Leukopenia—Thiotepa—sarcoma	0.000154	0.00233	CcSEcCtD
Dactinomycin—ABCC1—testis—sarcoma	0.000153	0.0128	CbGeAlD
Dactinomycin—Chills—Mitoxantrone—sarcoma	0.000153	0.00232	CcSEcCtD
Dactinomycin—Alopecia—Mitoxantrone—sarcoma	0.00015	0.00228	CcSEcCtD
Dactinomycin—Aplastic anaemia—Epirubicin—sarcoma	0.000148	0.00225	CcSEcCtD
Dactinomycin—Erythema—Mitoxantrone—sarcoma	0.000148	0.00225	CcSEcCtD
Dactinomycin—ABCG2—bone marrow—sarcoma	0.000148	0.0124	CbGeAlD
Dactinomycin—Agranulocytosis—Etoposide—sarcoma	0.000147	0.00223	CcSEcCtD
Dactinomycin—Myalgia—Thiotepa—sarcoma	0.000146	0.00222	CcSEcCtD
Dactinomycin—ABCC1—liver—sarcoma	0.000145	0.0121	CbGeAlD
Dactinomycin—Oesophagitis—Epirubicin—sarcoma	0.000144	0.00219	CcSEcCtD
Dactinomycin—Mouth ulceration—Epirubicin—sarcoma	0.000143	0.00217	CcSEcCtD
Dactinomycin—Anaemia—Vincristine—sarcoma	0.000141	0.00213	CcSEcCtD
Dactinomycin—Infection—Thiotepa—sarcoma	0.000139	0.00211	CcSEcCtD
Dactinomycin—Ill-defined disorder—Mitoxantrone—sarcoma	0.000137	0.00209	CcSEcCtD
Dactinomycin—Aplastic anaemia—Doxorubicin—sarcoma	0.000137	0.00208	CcSEcCtD
Dactinomycin—Sepsis—Epirubicin—sarcoma	0.000137	0.00208	CcSEcCtD
Dactinomycin—Thrombocytopenia—Thiotepa—sarcoma	0.000137	0.00208	CcSEcCtD
Dactinomycin—Anaemia—Mitoxantrone—sarcoma	0.000137	0.00208	CcSEcCtD
Dactinomycin—Leukopenia—Vincristine—sarcoma	0.000136	0.00207	CcSEcCtD
Dactinomycin—SLC22A5—testis—sarcoma	0.000135	0.0113	CbGeAlD
Dactinomycin—Erythema multiforme—Etoposide—sarcoma	0.000134	0.00203	CcSEcCtD
Dactinomycin—Malaise—Mitoxantrone—sarcoma	0.000134	0.00203	CcSEcCtD
Dactinomycin—Oesophagitis—Doxorubicin—sarcoma	0.000134	0.00203	CcSEcCtD
Dactinomycin—Anorexia—Thiotepa—sarcoma	0.000133	0.00203	CcSEcCtD
Dactinomycin—Phlebitis—Epirubicin—sarcoma	0.000133	0.00202	CcSEcCtD
Dactinomycin—ABCB1—myometrium—sarcoma	0.000133	0.0111	CbGeAlD
Dactinomycin—Leukopenia—Mitoxantrone—sarcoma	0.000133	0.00201	CcSEcCtD
Dactinomycin—Mouth ulceration—Doxorubicin—sarcoma	0.000132	0.00201	CcSEcCtD
Dactinomycin—Flushing—Etoposide—sarcoma	0.000131	0.00199	CcSEcCtD
Dactinomycin—Myalgia—Vincristine—sarcoma	0.000129	0.00197	CcSEcCtD
Dactinomycin—ABCB1—embryo—sarcoma	0.000128	0.0107	CbGeAlD
Dactinomycin—Hepatic failure—Epirubicin—sarcoma	0.000128	0.00194	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Thiotepa—sarcoma	0.000128	0.00194	CcSEcCtD
Dactinomycin—SLC22A5—liver—sarcoma	0.000127	0.0107	CbGeAlD
Dactinomycin—Chills—Etoposide—sarcoma	0.000127	0.00193	CcSEcCtD
Dactinomycin—Sepsis—Doxorubicin—sarcoma	0.000127	0.00193	CcSEcCtD
Dactinomycin—ABCG2—testis—sarcoma	0.000127	0.0106	CbGeAlD
Dactinomycin—Myalgia—Mitoxantrone—sarcoma	0.000126	0.00191	CcSEcCtD
Dactinomycin—Alopecia—Etoposide—sarcoma	0.000125	0.0019	CcSEcCtD
Dactinomycin—Discomfort—Mitoxantrone—sarcoma	0.000125	0.00189	CcSEcCtD
Dactinomycin—Oedema—Vincristine—sarcoma	0.000124	0.00188	CcSEcCtD
Dactinomycin—Infection—Vincristine—sarcoma	0.000123	0.00187	CcSEcCtD
Dactinomycin—Phlebitis—Doxorubicin—sarcoma	0.000123	0.00187	CcSEcCtD
Dactinomycin—Decreased appetite—Thiotepa—sarcoma	0.000122	0.00185	CcSEcCtD
Dactinomycin—Thrombocytopenia—Vincristine—sarcoma	0.000122	0.00185	CcSEcCtD
Dactinomycin—Oedema—Mitoxantrone—sarcoma	0.000121	0.00184	CcSEcCtD
Dactinomycin—Fatigue—Thiotepa—sarcoma	0.000121	0.00183	CcSEcCtD
Dactinomycin—Infection—Mitoxantrone—sarcoma	0.00012	0.00182	CcSEcCtD
Dactinomycin—ABCB1—seminal vesicle—sarcoma	0.00012	0.01	CbGeAlD
Dactinomycin—Pain—Thiotepa—sarcoma	0.00012	0.00182	CcSEcCtD
Dactinomycin—ABCG2—liver—sarcoma	0.00012	0.01	CbGeAlD
Dactinomycin—Thrombocytopenia—Mitoxantrone—sarcoma	0.000118	0.0018	CcSEcCtD
Dactinomycin—Anorexia—Vincristine—sarcoma	0.000118	0.0018	CcSEcCtD
Dactinomycin—Hepatic failure—Doxorubicin—sarcoma	0.000118	0.00179	CcSEcCtD
Dactinomycin—Lethargy—Epirubicin—sarcoma	0.000117	0.00178	CcSEcCtD
Dactinomycin—Feeling abnormal—Thiotepa—sarcoma	0.000115	0.00175	CcSEcCtD
Dactinomycin—Anorexia—Mitoxantrone—sarcoma	0.000115	0.00175	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Thiotepa—sarcoma	0.000114	0.00174	CcSEcCtD
Dactinomycin—Ill-defined disorder—Etoposide—sarcoma	0.000114	0.00174	CcSEcCtD
Dactinomycin—ABCB1—hematopoietic system—sarcoma	0.000114	0.00955	CbGeAlD
Dactinomycin—Anaemia—Etoposide—sarcoma	0.000114	0.00173	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Vincristine—sarcoma	0.000113	0.00172	CcSEcCtD
Dactinomycin—Malaise—Etoposide—sarcoma	0.000111	0.00169	CcSEcCtD
Dactinomycin—ABCC1—lymph node—sarcoma	0.000111	0.00929	CbGeAlD
Dactinomycin—Body temperature increased—Thiotepa—sarcoma	0.000111	0.00168	CcSEcCtD
Dactinomycin—Abdominal pain—Thiotepa—sarcoma	0.000111	0.00168	CcSEcCtD
Dactinomycin—Leukopenia—Etoposide—sarcoma	0.00011	0.00167	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00011	0.00167	CcSEcCtD
Dactinomycin—Lethargy—Doxorubicin—sarcoma	0.000108	0.00164	CcSEcCtD
Dactinomycin—Decreased appetite—Vincristine—sarcoma	0.000108	0.00164	CcSEcCtD
Dactinomycin—Fatigue—Vincristine—sarcoma	0.000107	0.00162	CcSEcCtD
Dactinomycin—Pain—Vincristine—sarcoma	0.000106	0.00161	CcSEcCtD
Dactinomycin—Liver function test abnormal—Epirubicin—sarcoma	0.000106	0.00161	CcSEcCtD
Dactinomycin—Decreased appetite—Mitoxantrone—sarcoma	0.000105	0.0016	CcSEcCtD
Dactinomycin—Fatigue—Mitoxantrone—sarcoma	0.000104	0.00158	CcSEcCtD
Dactinomycin—Discomfort—Etoposide—sarcoma	0.000104	0.00157	CcSEcCtD
Dactinomycin—Pain—Mitoxantrone—sarcoma	0.000103	0.00157	CcSEcCtD
Dactinomycin—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.000103	0.00157	CcSEcCtD
Dactinomycin—Aspartate aminotransferase increased—Epirubicin—sarcoma	0.000103	0.00157	CcSEcCtD
Dactinomycin—Hypersensitivity—Thiotepa—sarcoma	0.000103	0.00157	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Vincristine—sarcoma	0.000101	0.00154	CcSEcCtD
Dactinomycin—Asthenia—Thiotepa—sarcoma	0.0001	0.00152	CcSEcCtD
Dactinomycin—Infection—Etoposide—sarcoma	9.99e-05	0.00152	CcSEcCtD
Dactinomycin—Feeling abnormal—Mitoxantrone—sarcoma	9.96e-05	0.00151	CcSEcCtD
Dactinomycin—Dysphagia—Epirubicin—sarcoma	9.91e-05	0.0015	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Mitoxantrone—sarcoma	9.88e-05	0.0015	CcSEcCtD
Dactinomycin—Thrombocytopenia—Etoposide—sarcoma	9.84e-05	0.00149	CcSEcCtD
Dactinomycin—Abdominal pain—Vincristine—sarcoma	9.81e-05	0.00149	CcSEcCtD
Dactinomycin—Body temperature increased—Vincristine—sarcoma	9.81e-05	0.00149	CcSEcCtD
Dactinomycin—Liver function test abnormal—Doxorubicin—sarcoma	9.8e-05	0.00149	CcSEcCtD
Dactinomycin—SLC22A5—lymph node—sarcoma	9.75e-05	0.00817	CbGeAlD
Dactinomycin—Anorexia—Etoposide—sarcoma	9.58e-05	0.00146	CcSEcCtD
Dactinomycin—Diarrhoea—Thiotepa—sarcoma	9.58e-05	0.00145	CcSEcCtD
Dactinomycin—Body temperature increased—Mitoxantrone—sarcoma	9.56e-05	0.00145	CcSEcCtD
Dactinomycin—Abdominal pain—Mitoxantrone—sarcoma	9.56e-05	0.00145	CcSEcCtD
Dactinomycin—Toxic epidermal necrolysis—Doxorubicin—sarcoma	9.55e-05	0.00145	CcSEcCtD
Dactinomycin—Aspartate aminotransferase increased—Doxorubicin—sarcoma	9.55e-05	0.00145	CcSEcCtD
Dactinomycin—Pancytopenia—Epirubicin—sarcoma	9.41e-05	0.00143	CcSEcCtD
Dactinomycin—Neutropenia—Epirubicin—sarcoma	9.27e-05	0.00141	CcSEcCtD
Dactinomycin—ABCG2—lymph node—sarcoma	9.18e-05	0.00769	CbGeAlD
Dactinomycin—Dysphagia—Doxorubicin—sarcoma	9.17e-05	0.00139	CcSEcCtD
Dactinomycin—Hypersensitivity—Vincristine—sarcoma	9.15e-05	0.00139	CcSEcCtD
Dactinomycin—Hypersensitivity—Mitoxantrone—sarcoma	8.91e-05	0.00135	CcSEcCtD
Dactinomycin—Asthenia—Vincristine—sarcoma	8.91e-05	0.00135	CcSEcCtD
Dactinomycin—Vomiting—Thiotepa—sarcoma	8.9e-05	0.00135	CcSEcCtD
Dactinomycin—Pneumonia—Epirubicin—sarcoma	8.89e-05	0.00135	CcSEcCtD
Dactinomycin—Rash—Thiotepa—sarcoma	8.83e-05	0.00134	CcSEcCtD
Dactinomycin—Stevens-Johnson syndrome—Epirubicin—sarcoma	8.76e-05	0.00133	CcSEcCtD
Dactinomycin—Decreased appetite—Etoposide—sarcoma	8.74e-05	0.00133	CcSEcCtD
Dactinomycin—Pancytopenia—Doxorubicin—sarcoma	8.71e-05	0.00132	CcSEcCtD
Dactinomycin—Asthenia—Mitoxantrone—sarcoma	8.67e-05	0.00132	CcSEcCtD
Dactinomycin—Fatigue—Etoposide—sarcoma	8.67e-05	0.00132	CcSEcCtD
Dactinomycin—Stomatitis—Epirubicin—sarcoma	8.61e-05	0.00131	CcSEcCtD
Dactinomycin—ABCB1—uterus—sarcoma	8.61e-05	0.00721	CbGeAlD
Dactinomycin—Pain—Etoposide—sarcoma	8.6e-05	0.00131	CcSEcCtD
Dactinomycin—Neutropenia—Doxorubicin—sarcoma	8.58e-05	0.0013	CcSEcCtD
Dactinomycin—Diarrhoea—Vincristine—sarcoma	8.49e-05	0.00129	CcSEcCtD
Dactinomycin—Nausea—Thiotepa—sarcoma	8.31e-05	0.00126	CcSEcCtD
Dactinomycin—Feeling abnormal—Etoposide—sarcoma	8.29e-05	0.00126	CcSEcCtD
Dactinomycin—Diarrhoea—Mitoxantrone—sarcoma	8.27e-05	0.00126	CcSEcCtD
Dactinomycin—Agranulocytosis—Epirubicin—sarcoma	8.25e-05	0.00125	CcSEcCtD
Dactinomycin—Pneumonia—Doxorubicin—sarcoma	8.22e-05	0.00125	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Etoposide—sarcoma	8.22e-05	0.00125	CcSEcCtD
Dactinomycin—Stevens-Johnson syndrome—Doxorubicin—sarcoma	8.11e-05	0.00123	CcSEcCtD
Dactinomycin—ABCB1—lymphoid tissue—sarcoma	8.02e-05	0.00672	CbGeAlD
Dactinomycin—Stomatitis—Doxorubicin—sarcoma	7.97e-05	0.00121	CcSEcCtD
Dactinomycin—Body temperature increased—Etoposide—sarcoma	7.95e-05	0.00121	CcSEcCtD
Dactinomycin—Abdominal pain—Etoposide—sarcoma	7.95e-05	0.00121	CcSEcCtD
Dactinomycin—Hepatitis—Epirubicin—sarcoma	7.93e-05	0.0012	CcSEcCtD
Dactinomycin—Vomiting—Vincristine—sarcoma	7.89e-05	0.0012	CcSEcCtD
Dactinomycin—Pharyngitis—Epirubicin—sarcoma	7.87e-05	0.0012	CcSEcCtD
Dactinomycin—Rash—Vincristine—sarcoma	7.83e-05	0.00119	CcSEcCtD
Dactinomycin—Vomiting—Mitoxantrone—sarcoma	7.69e-05	0.00117	CcSEcCtD
Dactinomycin—Agranulocytosis—Doxorubicin—sarcoma	7.63e-05	0.00116	CcSEcCtD
Dactinomycin—Rash—Mitoxantrone—sarcoma	7.62e-05	0.00116	CcSEcCtD
Dactinomycin—Erythema multiforme—Epirubicin—sarcoma	7.5e-05	0.00114	CcSEcCtD
Dactinomycin—Hypersensitivity—Etoposide—sarcoma	7.41e-05	0.00112	CcSEcCtD
Dactinomycin—Nausea—Vincristine—sarcoma	7.37e-05	0.00112	CcSEcCtD
Dactinomycin—Flushing—Epirubicin—sarcoma	7.36e-05	0.00112	CcSEcCtD
Dactinomycin—Hepatitis—Doxorubicin—sarcoma	7.34e-05	0.00111	CcSEcCtD
Dactinomycin—ABCB1—bone marrow—sarcoma	7.3e-05	0.00612	CbGeAlD
Dactinomycin—Pharyngitis—Doxorubicin—sarcoma	7.29e-05	0.00111	CcSEcCtD
Dactinomycin—Asthenia—Etoposide—sarcoma	7.21e-05	0.0011	CcSEcCtD
Dactinomycin—Nausea—Mitoxantrone—sarcoma	7.18e-05	0.00109	CcSEcCtD
Dactinomycin—Chills—Epirubicin—sarcoma	7.12e-05	0.00108	CcSEcCtD
Dactinomycin—Alopecia—Epirubicin—sarcoma	7.01e-05	0.00106	CcSEcCtD
Dactinomycin—Erythema multiforme—Doxorubicin—sarcoma	6.94e-05	0.00105	CcSEcCtD
Dactinomycin—Erythema—Epirubicin—sarcoma	6.91e-05	0.00105	CcSEcCtD
Dactinomycin—Diarrhoea—Etoposide—sarcoma	6.88e-05	0.00104	CcSEcCtD
Dactinomycin—Flushing—Doxorubicin—sarcoma	6.81e-05	0.00103	CcSEcCtD
Dactinomycin—Chills—Doxorubicin—sarcoma	6.59e-05	0.001	CcSEcCtD
Dactinomycin—Alopecia—Doxorubicin—sarcoma	6.49e-05	0.000985	CcSEcCtD
Dactinomycin—Ill-defined disorder—Epirubicin—sarcoma	6.41e-05	0.000973	CcSEcCtD
Dactinomycin—Vomiting—Etoposide—sarcoma	6.39e-05	0.000971	CcSEcCtD
Dactinomycin—Erythema—Doxorubicin—sarcoma	6.39e-05	0.00097	CcSEcCtD
Dactinomycin—Anaemia—Epirubicin—sarcoma	6.38e-05	0.000969	CcSEcCtD
Dactinomycin—Rash—Etoposide—sarcoma	6.34e-05	0.000963	CcSEcCtD
Dactinomycin—ABCB1—testis—sarcoma	6.24e-05	0.00523	CbGeAlD
Dactinomycin—Malaise—Epirubicin—sarcoma	6.23e-05	0.000946	CcSEcCtD
Dactinomycin—Leukopenia—Epirubicin—sarcoma	6.18e-05	0.000939	CcSEcCtD
Dactinomycin—Nausea—Etoposide—sarcoma	5.97e-05	0.000907	CcSEcCtD
Dactinomycin—Ill-defined disorder—Doxorubicin—sarcoma	5.93e-05	0.0009	CcSEcCtD
Dactinomycin—Anaemia—Doxorubicin—sarcoma	5.91e-05	0.000897	CcSEcCtD
Dactinomycin—ABCB1—liver—sarcoma	5.9e-05	0.00495	CbGeAlD
Dactinomycin—Myalgia—Epirubicin—sarcoma	5.88e-05	0.000893	CcSEcCtD
Dactinomycin—Discomfort—Epirubicin—sarcoma	5.81e-05	0.000882	CcSEcCtD
Dactinomycin—Malaise—Doxorubicin—sarcoma	5.76e-05	0.000875	CcSEcCtD
Dactinomycin—Leukopenia—Doxorubicin—sarcoma	5.72e-05	0.000868	CcSEcCtD
Dactinomycin—Oedema—Epirubicin—sarcoma	5.64e-05	0.000856	CcSEcCtD
Dactinomycin—Infection—Epirubicin—sarcoma	5.6e-05	0.00085	CcSEcCtD
Dactinomycin—Thrombocytopenia—Epirubicin—sarcoma	5.52e-05	0.000838	CcSEcCtD
Dactinomycin—Myalgia—Doxorubicin—sarcoma	5.44e-05	0.000826	CcSEcCtD
Dactinomycin—Discomfort—Doxorubicin—sarcoma	5.37e-05	0.000816	CcSEcCtD
Dactinomycin—Anorexia—Epirubicin—sarcoma	5.37e-05	0.000816	CcSEcCtD
Dactinomycin—Oedema—Doxorubicin—sarcoma	5.22e-05	0.000792	CcSEcCtD
Dactinomycin—Infection—Doxorubicin—sarcoma	5.18e-05	0.000787	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Epirubicin—sarcoma	5.14e-05	0.00078	CcSEcCtD
Dactinomycin—Thrombocytopenia—Doxorubicin—sarcoma	5.11e-05	0.000775	CcSEcCtD
Dactinomycin—Anorexia—Doxorubicin—sarcoma	4.97e-05	0.000755	CcSEcCtD
Dactinomycin—Decreased appetite—Epirubicin—sarcoma	4.9e-05	0.000744	CcSEcCtD
Dactinomycin—Fatigue—Epirubicin—sarcoma	4.86e-05	0.000738	CcSEcCtD
Dactinomycin—Pain—Epirubicin—sarcoma	4.82e-05	0.000732	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Doxorubicin—sarcoma	4.75e-05	0.000721	CcSEcCtD
Dactinomycin—Feeling abnormal—Epirubicin—sarcoma	4.64e-05	0.000705	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Epirubicin—sarcoma	4.61e-05	0.0007	CcSEcCtD
Dactinomycin—Decreased appetite—Doxorubicin—sarcoma	4.53e-05	0.000688	CcSEcCtD
Dactinomycin—ABCB1—lymph node—sarcoma	4.53e-05	0.00379	CbGeAlD
Dactinomycin—Fatigue—Doxorubicin—sarcoma	4.5e-05	0.000683	CcSEcCtD
Dactinomycin—Pain—Doxorubicin—sarcoma	4.46e-05	0.000677	CcSEcCtD
Dactinomycin—Body temperature increased—Epirubicin—sarcoma	4.46e-05	0.000676	CcSEcCtD
Dactinomycin—Abdominal pain—Epirubicin—sarcoma	4.46e-05	0.000676	CcSEcCtD
Dactinomycin—Feeling abnormal—Doxorubicin—sarcoma	4.3e-05	0.000652	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Doxorubicin—sarcoma	4.26e-05	0.000647	CcSEcCtD
Dactinomycin—Hypersensitivity—Epirubicin—sarcoma	4.15e-05	0.00063	CcSEcCtD
Dactinomycin—Body temperature increased—Doxorubicin—sarcoma	4.12e-05	0.000626	CcSEcCtD
Dactinomycin—Abdominal pain—Doxorubicin—sarcoma	4.12e-05	0.000626	CcSEcCtD
Dactinomycin—Asthenia—Epirubicin—sarcoma	4.04e-05	0.000614	CcSEcCtD
Dactinomycin—Diarrhoea—Epirubicin—sarcoma	3.86e-05	0.000585	CcSEcCtD
Dactinomycin—Hypersensitivity—Doxorubicin—sarcoma	3.84e-05	0.000583	CcSEcCtD
Dactinomycin—Asthenia—Doxorubicin—sarcoma	3.74e-05	0.000568	CcSEcCtD
Dactinomycin—Vomiting—Epirubicin—sarcoma	3.58e-05	0.000544	CcSEcCtD
Dactinomycin—Diarrhoea—Doxorubicin—sarcoma	3.57e-05	0.000542	CcSEcCtD
Dactinomycin—Rash—Epirubicin—sarcoma	3.55e-05	0.00054	CcSEcCtD
Dactinomycin—Nausea—Epirubicin—sarcoma	3.35e-05	0.000508	CcSEcCtD
Dactinomycin—Vomiting—Doxorubicin—sarcoma	3.32e-05	0.000503	CcSEcCtD
Dactinomycin—Rash—Doxorubicin—sarcoma	3.29e-05	0.000499	CcSEcCtD
Dactinomycin—Nausea—Doxorubicin—sarcoma	3.1e-05	0.00047	CcSEcCtD
